Routine implementation costs of larviciding with Bacillus thuringiensis israelensis against malaria vectors in a district in rural Burkina Faso by Dambach, Peter et al.
Dambach et al. Malar J  (2016) 15:380 
DOI 10.1186/s12936-016-1438-8
RESEARCH
Routine implementation costs 
of larviciding with Bacillus thuringiensis 
israelensis against malaria vectors in  
a district in rural Burkina Faso
Peter Dambach1* , Michael Schleicher2, Hans‑Christian Stahl1, Issouf Traoré3, Norbert Becker4,5, Achim Kaiser4, 
Ali Sié3 and Rainer Sauerborn1
Abstract 
Background: The key tools in malaria control are early diagnosis and treatment of cases as well as vector control. 
Current strategies for malaria vector control in sub‑Saharan Africa are largely based on long‑lasting insecticide‑treated 
nets (LLINs) and to a much smaller extent on indoor residual spraying (IRS). An additional tool in the fight against 
malaria vectors, larval source management (LSM), has not been used in sub‑Saharan Africa on a wider scale since the 
abandonment of environmental spraying of DDT. Increasing concerns about limitations of LLINs and IRS and encour‑
aging results from large larvicide‑based LSM trials make a strong case for using biological larviciding as a complemen‑
tary tool to existing control measures. Arguments that are often quoted against such a combined approach are the 
alleged high implementation costs of LSM. This study makes the first step to test this argument. The implementation 
costs of larval source management based on Bacillus thuringiensis israelensis (Bti) (strain AM65‑52) spraying under dif‑
ferent implementation scenarios were analysed in a rural health district in Burkina Faso.
Methods: The analysis draws on detailed cost data gathered during a large‑scale LSM intervention between 2013 
and 2015. All 127 villages in the study setup were assigned to two treatment arms and one control group. Treatment 
either implied exhaustive spraying of all available water collections or targeted spraying of the 50 % most produc‑
tive larval sources via remote‑sensing derived and entomologically validated risk maps. Based on the cost reports 
from both intervention arms, the per capita programme costs were calculated under the assumption of covering the 
whole district with either intervention scenario. Cost calculations have been generalized by providing an adaptable 
cost formula. In addition, this study assesses the sensitivity of per capita programme costs with respect to changes in 
the underlying cost components.
Results: The average annual per capita costs of exhaustive larviciding with Bti during the main malaria transmis‑
sion period (June–October) in the Nouna health district were calculated to be US$ 1.05. When targeted spraying of 
the 50 % most productive larval sources is used instead, average annual per capita costs decrease by 27 % to US$ 
0.77. Additionally, a high sensitivity of per capita programme costs against changes in total surface of potential larval 
sources and the number of spraying repetitions was found.
Discussion: The per capita costs for larval source management interventions with Bti are roughly a third of the 
annual per capita expenditures for anti‑malarial drugs and those for LLINs in Burkina Faso which are US$ 3.80 and 3.00, 
respectively. The average LSM costs compare to those of IRS and LLINs for sub‑Saharan Africa. The authors argue that 
in such a setting LSM based on Bti spraying is within the range of affordable anti‑malarial strategies and, consequently, 
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Background
Malaria is still the most common vector-borne disease in 
sub-Saharan Africa, although the global number of cases 
and deaths diminished considerably since the 2000s, by 
18 and 48  %, respectively [1]. The former goal of global 
malaria eradication has been followed by an intensive 
public health focus on malaria control. Encouraged by 
recent control success, several countries now declared 
malaria elimination their policy target [2, 3]. Despite 
the historical success of malaria vector control through 
larval source management (LSM) [4], this method plays 
only a minor role on today’s sub-Saharan African policy 
agendas. Malaria vector control is mainly focused on 
strategies targeting adult mosquitoes. Long-lasting insec-
ticide-treated nets (LLINs) are considered the first-line 
vector control intervention supported by indoor resid-
ual spraying (IRS) for selected settings. These methods, 
indeed, prove to be highly effective but challenges remain 
due to mosquito resistance to insecticides [5–8] and the 
presence of mosquitoes which feed and rest outdoors [9]. 
In this light, malaria vector control through larval source 
management shows high potential to work as a comple-
mentary strategy for effective malaria control systems.
Larvicides based on the mosquito-specific toxins pro-
duced by Bacillus sphaericus (Bs) and Bacillus thur-
ingiensis israelensis (Bti) are promising tools for larval 
control. The selective nature of bacterial larvicides pre-
destines them for the use in community settings. While 
essentially non-toxic in their natural state, once ingested 
and digested by immature mosquitoes, these toxins 
selectively kill the larvae of vulnerable mosquito species 
[10–12]. The advantage of targeting the larval stages of 
mosquito vectors is that they are immobile, and in most 
environmental settings present in well-defined and eas-
ily accessible places. Unlike adult mosquitoes they can-
not change their behaviour to avoid control activities 
[13]. These larvicides operate on unique modes of action, 
allowing their use in resistance management programmes 
in vector control. In contrast to many other insecticides, 
to date no resistances to Bti have been observed in major 
malaria vectors [14].
Bti has been successfully used for decades in high-
income countries, primarily against nuisance mosqui-
toes, such as floodwater mosquitoes [13]. However, in 
countries where vector borne diseases are most preva-
lent, LSM is still a widely neglected approach, and its 
application, with some exceptions, is limited to research 
settings. Nevertheless, this limited strand of empirical 
evidence shows LSM to be effective in reducing malaria 
transmission in various settings [15]. Most formulations 
of Bti show a strong lethal effect on larval populations 
that lasts between 1 and 2  weeks, leading to substan-
tial reductions in adult vector densities [16–21]. Recent 
studies in East Africa have shown that larval control can 
reduce the abundance of malaria mosquito larvae and 
adult females by more than 90 % [22–24] and that com-
bined with long-lasting impregnated nets (LLINs) a two-
fold reduction in new malaria infections can be achieved 
compared to LLINs alone [22]. Further evidence was gen-
erated in Eritrea, where LSM as an additional component 
in the vector control programme led to a reduction of 
malaria of more than 50 % [25].
Until now, one of the main factors preventing broader 
implementation of LSM programmes is the perception 
that they come with comparably high costs and require 
complex supply infrastructure. This is partly reflected by 
the World Health Organization’s stance towards LSM. 
While the WHO recently adapted its guidelines for Bti-
based LSM and now recommends it for urban settings, 
rural areas are still considered ineligible due to alleged 
high programme costs [26]. To the authors´ knowl-
edge, this cost argument has not been convincingly con-
firmed by empirical evidence, so far. Based on detailed 
cost information gathered during the implementation 
of a large-scale Bti based LSM programme (henceforth 
called LSM) in rural Burkina Faso this study assesses the 
per capita programme costs for two different treatment 
choices. Cost calculations have been made transparent 
and reproducible for other settings by providing an easily 
applicable and adaptable cost formula. In addition, this 
study takes a disaggregated look at the programme cost 
structure by assessing the sensitivity of per capita pro-
gramme costs with respect to changes in the underlying 
cost components.
Methods
Study area
Home base of the project was Nouna, the capital town 
of the Kossi region, situated in the North Western part 
of Burkina Faso, close to the Mali border. Nouna itself 
with about 25.000 inhabitants is characterized as semi-
urban while the surrounding villages are rural. The health 
should deserve more attention in practice. Future research includes a cost‑benefit calculation, based on entomologi‑
cal and epidemiological data collected during the research project.
Keywords: Malaria, Bacillus thuringiensis israelensis, Vector control, Cost analysis, Larval source management, Burkina 
Faso, West Africa
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district comprises 127 rural villages ranging in size from 
several hundred to a maximum of a few thousands inhab-
itants. The population covered by the health district 
aggregates to a total of 156,000 (2013) and is served by 
a total of 43 rural health centres, delivering basic medi-
cal treatment within their catchment area of on average 
15  km radius [27]. Furthermore, those health centres 
serve as bases for health interventions, such as the dis-
tribution of insecticide-treated bed nets (ITNs) and vac-
cination campaigns.
Malaria transmission occurs throughout the year in 
Nouna, with a seasonal peak during the late rainy season 
between August and September. The entomological inoc-
ulation rate (EIR) which is defined as the number of infec-
tive bites per person per year amounted to 140 in 2002 
for the area around Nouna [28] compared to an average 
of 700 for the Sahel region of West Africa [28, 29]. The 
study area has been subject to a wide set of malaria con-
trol interventions including the distribution of ITNs [30], 
intermittent preventive treatment in pregnancy (IPTp), 
and early diagnosis and treatment of malaria cases. Indoor 
residual spraying (IRS) is not implemented.
Base study
The cost calculations are based on a prospective inter-
vention trial in the Nouna Health District, implemented 
between 2013 and 2015 [31]. The larviciding intervention 
with Bti strain AM65-52 was performed during the rainy 
season from June to end October. While the district capi-
tal Nouna itself received full treatment, all 127 villages in 
the district were allocated into one of the following three 
equally sized study arms:
i. Treatment of all larval sources with Bti every 10 days 
(in the following called S1 scenario).
ii. Targeted treatment of the 50 % most productive lar-
val sources, leaving the remaining 50  % least pro-
ductive larval sources untreated (in the following 
called S2 scenario). The criterion “most productive” 
was based on entomologically validated risk maps, 
described elsewhere [32, 33].
iii. Untreated control group with no larviciding per-
formed.
Cost calculations
The cost analysis consists of three steps, illustrated in 
Fig. 1. In step one, a comprehensive report on implemen-
tation costs based on detailed cost information gathered 
during the research project was established. In order to 
obtain full-scale per capita implementation costs, a sec-
ond step, seized the costs for each of the two treatment 
choices (S1 and S2) under the assumption of having cov-
ered the whole health district and excluding research 
related costs. The third step, comprises a generalized cost 
model, providing a tool to transparently reproduce cost 
calculations for other settings. Based on this model, the 
programme cost sensitivity with respect to changes in 
underlying cost components was assessed.
Assessment of project costs
Data were taken from the recorded project expendi-
tures of the EMIRA project (Ecologic Malaria Reduction 
for Africa) [31]. Recorded cost information was trans-
lated into a spreadsheet-based cost-report, presented 
in the Appendix (Additional file  1: Table S1). For each 
component of the spraying programme, data were gath-
ered from various sources. Larvicide consumption was 
recorded for each spray round at village level. Wages for 
fieldworkers were calculated based on the number of 
days worked for the programme, multiplied by a fixed 
daily rate. Costs for machinery, equipment and the lar-
vicide, as well as their shipping costs were obtained from 
invoices and sales receipts from all project partners. A 
discount rate to calculate the annualized economic costs 
was not applied for two reasons. First, most of the capi-
tal costs (knapsack sprayers and field material) are only 
used during the project duration and their recovery value 
is difficult to determine. Second, some of the equipment 
used for the application of GPS, computer and satellite 
imagery was provided within the infrastructure of the 
host organization. Savings accrued from these in-kind 
benefits broadly outweigh potential cost reductions that 
may arise from writing down other assets to their annual-
ized economic costs. The acquisition of satellite imagery 
and personnel costs for risk map creation were captured 
similarly. Costs were measured in the currency of the 
Fig. 1 Process of cost finding within the research project, transforma‑
tion to a routine implementation setting and upscaling of different 
larviciding strategies to the entire health district
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respective country (e.g. USA [US$], Germany/France [€], 
Burkina Faso [FCFA], and converted into US$ using a 
2013 through 2015 average exchange rate of 1US$ = 0.82 
€  =  531 FCFA (oanda.com). Consumables and utiliza-
tion of existing resources at the research centre (cars 
and drivers, etc.) were recorded using the research 
centre´s charges and allowances. Opportunity costs were 
excluded, (missed potential gains from alternative inter-
ventions when one intervention has been chosen) and the 
focus put on financial costs only.
In a further step, all research-related costs such as 
impact evaluation and university salaries that would not 
incur in a routine intervention were excluded. This step 
allowed for a cost comparison with other vector control 
approaches such as LLINs and IRS. Costs of international 
staff were replaced with those for local personnel where 
possible. External specialists for LSM, remote sensing 
and risk map creation were kept since those might not be 
locally available in comparable settings.
Scenario upscaling
Accrued project implementation costs were recorded for 
both treatment scenarios, which accounted for roughly 
one-third of the study population each. These costs were 
extrapolated to the entire health district comprising 127 
rural villages and the district capital. Based on practical 
experience gathered during implementation, the follow-
ing adjustments were performed before conducting the 
scale-up calculations. Due to high heterogeneity in size 
and number of larval breeding sites across villages, an 
hour-based pay scheme was introduced to account for 
the varying workloads for spray personnel. Equally, the 
fixed number of two sprayers per village employed dur-
ing the research project was adjusted to one person who 
is paid for the hours worked. For a small percentage of 
spray-intensive villages additional spray personnel was 
budgeted. This means the personnel needs between dif-
ferent treatment scenarios are expressed through work-
load and not by the number of people per se.
An estimated total of 150 persons would be needed 
to cover the entire health district including the district 
capital. This roughly translates into one person per vil-
lage plus 15 additional sprayers reserved for some villages 
which show more than 1.5 hectares of larval sources, 
which is roughly the surface that can be treated by one 
person per day. These adjustments differ from the setup 
in the research project, where the required workforce 
was overestimated for most villages and two fieldwork-
ers with spraying equipment were employed per village. 
According to the personnel adjustments from above a 
total of 25 supervisors would be needed to ensure qual-
ity control of the larviciding actions by revisiting larval 
sources and sampling larvae.
Modelling of programme costs
To allow for a more generalized calculation of implemen-
tation costs for different settings, we derived a cost for-
mula that explains the relationship between programme 
costs and its components. The contribution from such an 
exercise is twofold: First, it sheds light into the cost struc-
ture of a large-scale LSM programme in the highly relevant 
context of a malaria stricken sub-Saharan African country. 
Second, the formula provides a fair estimate of per capita 
implementation costs for Bti-based LSM, using reference 
values from the EMIRA project, from previous findings 
and from literature as input variables (Table 1). Thus, the 
formula easily accounts for a wide range of implementa-
tion scenarios, such as a changed larvicide market price or 
labour wage rate. By controlling for different geographic 
conditions (e.g. the duration of the rainy season), differ-
ent Bti formulations (e.g. re-treatment interval, larvicide 
concentration) and treatment productivity (e.g. application 
mode, distribution of breeding sites) the presented cost-
model can be regarded as a suitable ex-ante assessment 
tool for upcoming LSM interventions.
As shown in Eq.  (1) the total programme costs were 
disaggregated (CTOTAL) into seven cost components. 
Each component in turn, is expressed as a function of its 
underlying cost variables and will be further explained in 
the following.
Larvicide needs and spraying apparel (Eq. 2)
Total larvicide-related costs (CLARV) contain the cost for 
obtaining the needed quantity of larvicide (CBTI) as well 
as corresponding spraying material (CBTIMAT) and are 
presented in Eq. (2).
First, CLARV depends on the exogenously given lar-
vicide market price (CPBTI) measured in US$ per kg. 
Expenses for shipping the product from the US to 
Burkina Faso, including insurance and clearance fees 
(Manufacturer Valent Biosciences, exchange rates US$ 
to € averaged 2013–2015) were included. Storage of 
the product once it arrived at district level was consid-
ered under operations costs and overheads. The spray-
ing interventions were run with VectoBac® WG, a water 
dispersible granule formulation of Bacillus thuringien-
sis israelensis strain AM65-52 from Valent BioSciences 
Corp., Illinois, USA with a potency of 3000 ITU/mg 
(International Toxic Units).
Second, larvicide-related costs depend on the ultimate 
choice of the utilized Bti concentration (BtiConc). In our 
setting, the Bti granules were suspended in water prior 
to usage and dispersed in stagnant environmental water 
bodies using knapsack sprayers (Model: 3595 INOX, 
Mesto Corp., Freiberg, Germany).
(1)
CTOTAL = CLARV + CSPRAY + CQUAL + CPMT
+ CMAP + CTRANS + COVER
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Third, the amount of larvicide needed depends highly 
on the duration of the intervention within a year, which 
for its part is driven by the onset and cessation of the 
rainy season. Moreover, implications for larvicide con-
sumption arise from the treatment interval, the number 
of days one waits until the next spraying is conducted. 
When deciding on the optimal interval length the follow-
ing trade-off arises: from a cost perspective the interval 
should be maximally stretched while shorter treatment 
intervals ensure that a maximum of larvae are hindered 
to develop into adult vector mosquitoes [17]. Both fac-
tors, duration and treatment interval are reflected by the 
variable Repetitions, the number of treatments per year 
for every eligible unit.
Another factor exerting influence is the buffer radius 
chosen to be treated around a village, accounting for the 
mosquitoes’ flight range and their possible infiltration 
from outside into treated areas. The buffer radius is not 
separately included within the cost formula but is rep-
resented through the total surface of breeding sites in 
the vicinity of villages (TotalSurface). The variable Cov-
eredSurface accounts for both treatment scenarios, the 
100  % (CoveredSurface =  1) and the 50  % (CoveredSur-
face = 0.5) treatment.
Finally, the costs for corresponding spraying material 
are added to the equation where the number of sprayers 
is approximated and multiplied with the costs of knap-
sack sprayer equipment per person (CBTIMAT). The latter 
were accounted similarly to CBTI, but with transport from 
Germany.
Staff requirements and costs (Eqs. 3–5)
A large-scale LSM programme requires the employ-
ment of different types of personnel. For project man-
agement, risk map creation, and entomological training 
highly trained professionals are required, while for spray-
ing activities laypersons from the villages can be hired 
and trained within a short time. Calculation of personnel 
costs is based on the research centre´s guidelines, which 
follow recommendations by the ministry of health and 
may be similar within the region. Based on the experi-
ence, with a 5-month implementation period, spray per-
sonnel would have to work approximately only on 15 days 
in total.
As it can be seen in Eq. (3) costs for spraying activities 
(CSPRAY) can be described as product of four factors. The 
(2)
CLARV = CBTI + CBTIMAT
= (CPBTI ∗ BtiConc ∗ Repetitions
∗ TotalSurface ∗ CoveredSurface)
+
(
CPMAT ∗
TotalSurface
Sprayer Pr oductivity ∗Hours Per Day
)
first four factors determine the total amount of working 
hours needed for spraying which is then multiplied with 
the hourly rate.
The costs for quality control (CQUAL) are expressed in 
Eq. (4). In this setting, the corresponding effort for send-
ing supervisors to the field amounts to 30–35  days per 
season. In contrast to spraying personnel supervisors 
are differently qualified and follow another project plan 
with spot tests at several treatment units or villages per 
day. Thus, Eq. (4) shows a similar structure to Eq. (3) but 
assumes different values for labor productivity (Supervi-
sorProductivity) and hourly rates (SupervisorWage). The 
percentage of total surface selected for quality control 
spot tests (SampleSurface) is variable and can be cho-
sen by the programme manager. Here, a tradeoff is faced 
between high quality control standards and lower per-
sonnel costs.
Costs for project management and training (CPMT) are 
presented in Eq. (5). The personnel costs for the project 
manager (CPM), as well as those of the entomological 
technicians (CLSM) were calculated as monthly salaries 
multiplied by the number of months involved in the pro-
ject. The costs for community sensitization (CMSZ) and 
training events (CTRAIN) are rather dependent on their 
complexity and duration than on the sheer number of 
people and are therefore additively linked.
Mapping and risk map creation (Eq. 6)
Two different types of maps were used in the underlying 
intervention study, depending on the chosen intervention 
scenario. Consequently, costs for mapping and risk map 
creation differed by treatment scenario and are presented 
in Eqs. (6) and (7). Both treatment choices required map-
ping of larval sources prior to map creation. While for the 
S1 scenario all breeding sites had to be mapped individu-
ally to obtain a map with their positions (CSOURCE), the S2 
scenario needed only mapping of a defined percentage of 
breeding sites including their vector larvae productivity 
(CRISK). Regarding the latter, satellite image analysis was 
performed to generate a risk map of the villages in ques-
tion (CGIS). The costs for the S2 scenario included pur-
chasing of SPOT 5 satellite imagery from ASTRIUM Geo 
(3)
CSPRAY = Repetitions ∗
TotalSurface
Sprayer Pr oductivity
∗ Surface
∗ CoveredSurface ∗ SprayerWage
(4)
CQUAL = Repetitions ∗
TotalSurface
Supervisor Pr oductivity
∗ SupervisorWage ∗ Surface
∗ CoveredSurface ∗ SampleSurface
(5)CPMT = CPM + CLSM + CMSZ + CTRAIN
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Information Services (CSAT), while GPS handheld devices 
and software licenses were required for both scenarios 
(CEQP).
Transport costs and overheads (Eqs. 7 and 8)
Transport costs (CTRANS), presented in Eq. (8), are given 
as the product of repetitions and cumulated transport 
costs per treatment round (CTRANSROUND). The latter 
includes expenditures for the use of cars and motorbikes. 
It equally covers proportionate salaries of drivers and 
allowances. Transport costs mainly occur during field 
missions to the villages where spraying is performed to 
deliver the larvicide, hold sensitization meetings, and 
locally coordinate with spray teams.
Overheads (COVERSUBTOTAL) comprise office and stor-
age space requirements, insurance, security, and other 
office support requirements, such as stationary, printing, 
communication and field mission coordination. Equally 
consumables not represented as separate budget items 
and were included within overheads. Remaining person-
nel expenses spent on short-term consultancies were 
included in overheads (e.g. secretary, accountant).
Sensitivity analysis of per capita intervention costs
The last part of our cost calculation approach describes 
the sensitivity analysis that builds on the Bti cost model 
(0). The variables chosen were either fixed a priori within 
the programme protocol, e.g. the surface of the treatment 
buffer around villages, the utilized Bti concentration, and 
the treatment interval (in the following called endog-
enous factors) or they were subject to local environmen-
tal settings, e.g. the average total surface of larval sources 
per village (in the following called exogenous factors).
Based on the reference values from our intervention, 
from literature and from own preceding field studies [17, 
31], a reasonable interval with lower and upper limits for 
each variable was determined. Since the underlying base-
line values were taken from effectively accrued costs, no 
confidence intervals were available to fix the minimum 
and maximum values. Instead we used a 20 % fluctuation 
range for most personnel and material costs. The variable 
population density was excluded from the formula. This 
is because those data are commonly only available for a 
predefined region but hardly for an area of treatment in 
and around villages. Instead the formula facilitates the 
(6)
S1 scenario (100 percent treatment):
CMAPS1 = CEQP + CSOURCE
(7)
S2 scenario (50 percent treatment):
CMAPS2 = CEQP + CGIS + CSAT + CRISK
(8)CTRANS = Repetitions ∗ CTRANSROUND
(9)COVERSUBTOTAL = Subtotal Costs ∗ MOVERHEAD
calculation of total programme costs, which can after-
wards easily be divided by the population domiciled in 
the villages that are covered by spraying activities.
R1 The price for Bti refers to the formulation and manu-
facturer used within the underlying field study (Vecto-
bac® WG, formerly WDG, Valent Biosciences Corp.). 
With the same product, semi-terrain studies on lethal 
dosages were performed [17]. The costs for the larvi-
cide were combined with the costs for different freight 
options. The baseline and maximum values represent 
typical airfreight costs from the US to West African 
countries. Total airfreight costs increase virtually line-
arly with the amount of larvicide ordered. The minimum 
value represents the cheapest offer by sea cargo which is 
usually not bound to weight but to volume, e.g. per con-
tainer space. The volatility of the dollar to euro exchange 
rate over the last 3 years was included into our minimum 
and maximum value calculations since many West Afri-
can currencies are pegged to the Euro. Average exchange 
rates for 2013, 2014 and 2015 were used.
R2 The efficacy of Bti formulations against Culicidae lar-
vae depends on various factors, including water pollution, 
water depth, water temperature and others. The baseline 
value corresponds to the concentration used during the 
study, the minimum value showed efficacy in semi-field 
trials in the region and could still be effective in achieving 
>95  % lethality on mosquito larvae. The upper threshold 
might be needed if Culex mosquitoes should become a tar-
get, which often breed in heavily polluted breeding sites.
R3 The number of repetitions is the product of the period 
of intervention (months per year) and the spraying fre-
quency (spray rounds per month). It depends on the 
duration of the rainy season and the persistence of larval 
breeding grounds. The given minimum and maximum 
values do not only attribute for the interannual variations 
in the onset and duration of the rainy season [34] but 
reflect a possible shift of the region of implementation 
further North or South by some 100 km. The number of 
repetitions can be equally influenced by the use of other 
Bti formulations or differences in temperature which will 
determine the spraying frequency via their influence on 
larval development.
Results
Accrued costs for LSM in the underlying research setting
All expenditures that accrued during the 3-year project 
were recorded and assigned to respective cost categories. 
The overall costs of the project as it was performed in the 
field amounted to US$ 563,690, including research related 
costs (see Additional file 1: Table S1). Those research related 
costs are provided by Additional file 1: Table S1 to increase 
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transparency and to facilitate replicability. Research related 
costs were excluded during the following upscaling pro-
cess. During the two intervention years of the study a total 
of 1800 kilograms of Bti powder were deployed, inducing 
expenditures of roughly US$ 73,000, including freight costs, 
this figure increases to US$ 94,000, accounting for 16 % of 
the total costs of the research project. Within the research 
setting personnel costs amounted to roughly US$ 322,000, 
which represents almost two-third of total programme 
costs. More than half of those costs were consumed by the 
salary of an external scientific coordinator. Additional US$ 
50,000 were used for the implementation of impact evalua-
tion tools. Research-related costs amounted roughly to US$ 
257,000 which represents 45 % of total programme costs.; 
they would not incur during a routine implementation of 
larviciding activities.
Upscaling of per capita intervention costs
The programme costs were calculated under the assump-
tion of covering the whole health district and running 
the programme for 3  years for both treatments (S1 and 
S2) (see Table 2). Three different costing results are pro-
vided: Column (1) shows, the costs per person protected 
for the first intervention year. Column (2) presents costs 
for running the project an additional year while column 
(3) gives the average costs over the assumed programme 
duration of 3 years. The latter allows the best estimation 
of incurring cost per year and the comparison with other 
vector control methods, and are hence used for further 
consideration.
The total annual costs averaged over 3 years for the S1 
scenario were estimated at US$ 163,038 to cover 156,000 
people in a mostly rural area with villages distributed 
over 4200 km2. The total annual costs for the S2 sce-
nario amounted to US$ 120,239. The costs per person 
protected per year were calculated to be US$ 1.05 and 
US$ 0.77 for the S1 and S2 scenarios respectively. Over 
3 years, the recurrent costs comprised about 80 % of the 
total programme costs for both S1 and S2. The highest 
share of costs was attributable to larvicide within the S1 
scenario with 41.6 % of total costs while for the S2 sce-
nario larvicide and its transport only amounted to 28.0 % 
of total costs. Personnel costs made up 34.7  % of total 
costs in the S1 scenario while their proportion was mark-
edly higher in the S2 scenario with 42.7 %.
Sensitivity analysis of per capita intervention costs
The sensitivity analysis evaluates the responsiveness of 
the programme’s per capita costs towards changes in 
major cost component variables. Results are interpreted 
in a ceteris paribus fashion; A component’s effect on total 
programme costs is assessed while keeping all other cost 
components constant. The selection of input variables is 
directly based on the Bti cost model introduced in the 
above section (Eq. 1). Based on its magnitude, relevance 
and simplicity of interpretation the following five vari-
ables are included in the sensitivity analysis; TotalSurface, 
Repetitions, BtiConcentration, SprayerWage, BtiCost.
The first part of the analysis looks into the elasticity of 
programme costs; the percentage change in programme 
costs when the cost of only one component increases by 
1 %. Figure 2 illustrates the corresponding results for both 
scenarios. Since elasticities behave symmetrically it is suf-
ficient to only depict one direction of the cost component 
change. Two exogenous factors, total surface and sprayer 
wage determine the boundaries of cost elasticity. For sce-
nario 1, a 1 % increase in total surface leads to a 0.84 % cost 
increase while a 1 % increase in sprayer wage leads only to a 
0.25 % cost increase. Increasing the number of repetitions by 
1 % still leads to substantial increases in programme costs 
of about 0.78 and 0.65 %, for the first and second scenario 
respectively. Programme costs show moderate changes 
related to an increase in the price and utilized concentration 
of Bti of about 0.45 and 0.38 % in S1 and S2, respectively.
Further, there is interest how absolute values of per 
capita programme costs change with respect to the deter-
mined interval-width of component costs. Such an illus-
tration in absolute terms contains useful information 
about the directly accrued cost changes one would expect 
in the field. For both scenarios this is presented in Figs. 3 
and 4, respectively. Relative to the elasticity representa-
tion it can be observed that Bti costs now show a rela-
tively smaller effect since the current level of Bti prices is 
judged to be quite high, already. The latter also explains 
the relatively high swing to the left of the baseline value. 
In absolute terms, increasing total surface by 20 % (from 
240 to 288 hectares) leads to an increase in total per cap-
ita programme costs of about US$ 0.17. High sensitivity 
equally originates from the number of spray rounds per-
formed during a year. An extension or shortening from 
the standard 15 rounds of larvicide application by 20  % 
(equaling 1 month of intervention), will increase or lower 
the intervention costs by roughly US$ 015 (US$ 0.09 for 
S2). The following parameters have much less impact on 
the intervention costs when varying within their prede-
fined borders. All parameters that have a lower impact on 
the per capita costs than 1  % are not shown. The mod-
elled total programme costs were divided by the number 
of inhabitants (156,000) that would be covered in a pro-
gramme run in the complete health district. 
When substituting the hourly payment scheme of the 
costing model with a daily payment scheme based on 
the number of spray rounds performed, calculated costs 
increase by about 14  % (23  % for S2). A daily payment 
scheme is easier to implement in areas where one can 
find delimited villages rather than a coherent treatment 
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area. In such a setting the amount of spraying apparel 
increases disproportionally since equipment will remain 
within one village even if there are only few breeding 
sites to treat. In a strictly village-based treatment scheme 
the difference between a S1 and a S2 scenario reduces 
because the minimum requirement of sprayers per village 
is one person. For more coherent settlements or areas 
with villages close to each other though, an hourly treat-
ment scheme seems more appropriate to calculate costs, 
since spray personnel and knapsack sprayers can be dis-
tributed as needed within that region.
Discussion
It was found that the implementation of a comprehen-
sive LSM coverage of the Nouna health district, would 
incur annual per capita costs of US$ 1.05 (US$ 0.77 for S2 
scenario) over a project lifetime of 3  years. Other stud-
ies [23, 35, 36] found similar values ranging between US$ 
0.90 and 2.50, with the general tendency of lower per 
capita costs in urban settings. In the Upper-Rhine valley 
in Germany a mosquito control programme using Bti-
based routine LSM has been carried out on a large-scale 
operational basis since 1992. It’s per capita costs of US$ 
Table 2 Costs for LSM in US$ in the Nouna health district comprising 127 rural villages and the semi-urban district capital
Costs per person protected are based on a 2013 midyear population of 156.000 inhabitants. Calculations based on 2013 costs for material and personnel using a 
2013–2015 average exchange rate of US$ 1 = € 0.82
Implementation year Following program year Average annual costs 
over 3 years
Proportion 
of total costs 
(%)
S1 S2 S1 S2 S1 S2 S1 S2
Recurrent costs (personnel)
 Project manager Burkina Faso 9.800 9.800 9.800 9.800 9.800 9.800
 LSM specialist 4.200 4.200 2.100 2.100 2.800 2.800
 Entomologic technicians 4.800 4.800 4.800 4.800 4.800 4.800
 GIS specialist 4.200 1.400
 Larviciding personnel 28.000 22.500 28.000 22.500 28.000 22.500
 Larviciding supervisors 7.750 7.750 7.750 7.750 7.750 7.750
Subtotal 54.550 53.250 52.450 46.950 53.150 49.050 35.9 44.9
Consumables
 Larvicide 56.000 28.000 56.000 28.000 56.000 28.000
 Air freight larvicide 14.500 7.250 14.500 7.250 14.500 7.250
Subtotal 70.500 35.250 70.500 35.250 70.500 35.250 47.6 32.2
Transport costs
 In country travel and field work 5.700 6.900 5.700 5.700 5.700 5.700
Subtotal 5.700 6.900 5.700 5.700 5.700 5.700 3.8 5.2
Activities
 Staff training 3.800 3.800 2.000 2.000 2.600 2.600
 Community sensitization 3.200 3.200 1.067 1.067
 Mapping of larval sources 1.800 600
 Mapping for risk map creation 2.800 933
Subtotal 8.800 9.800 2.000 2.000 4.267 4.600 2.9 4.2
Capital costs
 Knapsack sprayers 36.000 36.000 12.000 12.000
 Air freight knapsack sprayers 7.700 7.700
 GPS, computer, equipment 2.500 2.500 833 833
 Satellite imagery 1.650 550
 Protective clothes 5.300 3.975 1.767 1.325
Subtotal 51.500 51.825 14.600 14.708 9.9 13.5
Total 191.050 157.025 130.650 89.900 148.217 109.308
Overheads 10 % 19.105 15.703 13.065 8.990 14.822 10.931
Total program costs 210.155 172.728 143.715 98.890 163.038 120.239
Costs per person protected 1.35 1.11 0.92 0.63 1.05 0.77
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1.18, are in a comparable range [37] even though insti-
tutional, economic and environmental conditions are 
highly different. In this setting of a developed country, 
high population density and high degree of mechaniza-
tion outweigh the relatively high costs for salaries. The 
calculated per capita intervention costs for Bti-based 
LSM in Burkina Faso compare with the lower limit of 
costs for indoor residual spraying, which range from 
US$ 0.88–4.94 per person protected [38]. They are also 
slightly below the costs for long-lasting impregnated 
bed nets (LLINs) in sub-Saharan Africa, which are in the 
range of US$ 1.38–1.90 [39]. The per capita costs for lar-
viciding in the underlying setting were significantly lower 
than those for conventional ITNs which range between 
US$ 1.21 in Eritrea and US$ 6.05 in Senegal [38, 39] and 
were found to have median standardized costs of US$ 
Fig. 2 Elasticity of cost factors for the S1 and S2 scenario. The diagram shows the percentage change of costs per person and year protected if the 
cost factor varies by 1 %
Fig. 3 Sensitivity analysis of costs per person and year protected for S1. Dependencies of costs on deviation from the baseline value are shown for 
the five most influential parameters. Intervals for the depicted cost components are: CBTI: −16/6 %; SprayerWage: −20/20 %; BtiConc: −14/14 %; 
Repetitions: −20/20 %; TotalSurface: −20/20 %
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2.20 per year [40]. Compared to the national per capita 
expenditures in Burkina Faso for LLINs and anti-malarial 
drugs which amount to US$ 3.00 and US$ 3.80, respec-
tively [41], costs for larviciding were significantly lower.
The programme’s per capita costs were calculated in 
two different ways. The method of upscaling is naturally 
bound strongly to expenditures that were seized during 
the research project. The Bti cost model tries to unfold 
the programme’s underlying cost structure and, at the 
same time, provide an ex-ante assessment tool, suitable 
for LSM interventions in similar settings. In contrary to 
the up-scaled costs, the cost model generalizes more, e.g. 
the needed workforce is broken down on hourly base. 
As a result, per capita intervention costs slightly differ 
between both approaches. For the above comparison 
with other control measures we used the values calcu-
lated during the upscaling process.
The costs per person protected are driven mainly by 
two factors, the water surface to be treated and the num-
ber of inhabitants that benefit from the intervention in 
the respective village. Furthermore, the costs of larvi-
ciding depend on the region’s ecology, e.g. the number 
of months with persisting larval sources in the environ-
ment. In the setting of North Western Burkina Faso, the 
highest transmission of malaria takes place during the 
5 months of the rainy season (June through October). In 
areas with two rainy seasons or year round rainfall, the 
costs of a larviciding programme are likely to increase, 
while in areas with a shortened rainy season costs will 
decrease. Climatic changes might equally show impact 
on the required duration of larviciding activities in future 
[42].
There are limitations to the economically efficient 
application of LSM for areas with a high annual malaria 
transmission and vast areas covered by surface water [20, 
43–45]. However, in the light of recent control efforts 
with LLINs, more areas show reduced malaria transmis-
sion during an increased number of months [25, 36]. 
This would make the additional implementation of lar-
vicide-based LSM economically suitable even in previ-
ously unsuitable regions, provided it is part of integrated 
malaria control, i.e. applied together with medical treat-
ment, LLINs and IRS. Although the WHO recommends 
that “larviciding should be considered for malaria control 
(together with or without other interventions) only in 
areas where the larval habitats are few, fixed and finda-
ble” [26] the Cochrane Review of Tusting et al. [15] sum-
marized evidence for high success at reasonable costs 
even for regions where the WHO criteria are not fulfilled, 
which is in line with the results of this study.
The targeted treatment strategy might prove to be 
especially useful in settings with a high number of larval 
sources and a prolonged duration of vector abundance 
and hence malaria transmission. Here, reducing the area 
to be sprayed by targeting only highly productive water 
bodies using remote sensing could be an effective and 
cost-reducing option. It is known that not all water bod-
ies are appropriate for malaria vector development [44, 
46] and costs can be reduced if only those with increased 
larval productivity are treated [32, 33]. In this research 
Fig. 4 Sensitivity analysis of costs per person and year protected for S2. Dependencies of costs on deviation from the baseline value are shown for 
the five most influential parameters. Intervals for the depicted cost components are: CBTI: −16/6 %; SprayerWage: −20/20 %; BtiConc: −14/14 %; 
Repetitions: −20/20 %; TotalSurface: −20/20 %
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setup, a threshold of 50 % of the expected most produc-
tive water bodies to treat within the larviciding scenario 
S2 was chosen. Though this threshold might be increased 
or lowered in view of different environmental conditions, 
it should ideally follow the absolute larval productivity 
per surface.
We found the S2 scenario to have roughly 26 % lower 
costs of treatment than the S1 scenario, primarily due to 
savings on larvicide and personnel costs. Results from 
the EMIRA study show an average mosquito reduction in 
the S2 study arm of roughly 65 %, compared to 80 % in 
the S1 scenario (Dambach, unpublished data). At a later 
stage, savings in treatment costs have to be thoroughly 
evaluated against the lower achieved reductions in vec-
tor abundance. Risk map based larviciding is particularly 
interesting for settings with a large number of environ-
mental larval sources, since in such environments costs 
for larvicide and workforce increase disproportionally 
under a full coverage scenario. On the other hand, this 
requires a high prediction accuracy of the risk model 
and the existence of larval sources with low or no larval 
productivity [47]. In settings where the majority of water 
bodies is infested with vector larvae, like it was the case 
in the study region, exhaustive larviciding would be the 
better choice. The deductions compare to results of some 
other studies that found high degrees of larval infestation 
regardless of the type of breeding site [48, 49]. In other 
areas with high heterogeneity in breeding site infesta-
tion, targeted interventions might be an opportunity to 
cut down on personnel costs as another large-scale trial 
has shown for dengue [50]. Technological developments 
such as new larvicide formulations with longer residual 
effects through encapsulation and via the combination 
with other larvicides will substantially reduce treatment 
costs. Those would drop by roughly 25 % if the treatment 
intervals were extended from 10 to 14 days. Innovations 
such as airborne dispersal via unmanned aerial vehicles 
might further reduce programme costs [51].
The calculations presented here are the basis for a cost-
effectiveness analysis to come, evaluating the entomo-
logic and health impact indicators [31]. A crucial factor 
for a cost-effectiveness analysis at a later stage is to meas-
ure the attributable effect of LSM on health outcome 
indicators. Cost calculations were based on the project 
duration of 3  years, although several items of the capi-
tal costs might have a significantly longer service life. If 
implemented as a routine vector control measure costs 
for personnel training and sensitization would equally 
decline.
Despite differences in climate, environment and pop-
ulation densities in other parts of Burkina Faso and 
neighboring countries, the presented findings can be a 
useful reference to calculate budget needs for similar 
implementations, be it regional or nationwide. Those 
would add onto the national health expenditures of US$ 
39.00 per person and year [41]. In developing countries 
such as Burkina Faso though, to date such an interven-
tion, even if cost effective in terms of its protection 
against malaria, needs funding from external donors. In 
the light of our findings one of the main points of criti-
cism towards LSM, their perceived high costs, should be 
revised for a number of settings. The results show that 
LSM based on Bti spraying can be an affordable com-
plementary approach for integrated malaria control. 
Further in-depth research is needed to more comprehen-
sively compare the programme costs and malaria con-
trol benefits across different approaches. With respect 
to this intervention study, such an analysis is planned 
for future research and will assess the cost-effectiveness 
based on parasitaemia and malaria-related morbidity and 
mortality.
There are several strengths and limitations to this study. 
To the authors’ knowledge this is the first study that 
empirically assessed Bti larviciding costs in West Africa 
based on a large-scale LSM project. The presented cost 
report draws on effectively accrued expenses and serves 
as a reliable indicator for projects in similar settings. On 
the other hand, this very detailed calculation bears limi-
tations. If the programme costs are to be compared with 
those from other settings, e.g. east Africa or Asia, differ-
ences in organizational frameworks and their guidelines 
such as from the ministry of health and locally perform-
ing institutions are likely to substantially affect the inter-
vention’s cost structure.
A further problem of calculating programme costs is 
the exchange rate to foreign currencies. Many of the fran-
cophone West African countries are part of monetary 
unions (BEAC, BCEAO) that use currencies which are 
pegged to the Euro. Exchange rate fluctuations between 
Euro and US Dollar may have significant impact on pro-
ject costs, making non-European Union financed pro-
jects more or less attractive for donor organizations. 
Project costs may hence vary depending on where the 
project is run and from which sources Bti and other 
material are obtained. A further limitation to this study is 
the application of a 50 % treatment threshold for larvicid-
ing. In the present study, this threshold was deliberately 
set to gather data on the achievable reduction with only 
the most productive half of water bodies treated. From an 
epidemiological point of view, it would be rather advis-
able to not work with an a priori set threshold of treated 
water bodies but an absolute threshold of larval densities, 
which if exceeded, indicates the need for treatment. For 
many settings it could turn out that larval productivity 
is still high although the breeding sites belong to the half 
with the lower larval densities.
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Several assumptions based on field experience were 
introduced to calculate needed programme resources. 
The number of required spray personnel was set a priori 
to one person per village based on the observations of a 
low number of vector breeding sites in most of the vil-
lages. Despite the technically sufficient workforce it may 
be generally an advantage to employ sprayers as teams of 
two or more to increase motivation and backup security 
in the case of illness or absence. An increase in person-
nel would not significantly increase cost for wages on an 
hourly basis but it would double the need for spraying 
equipment.
The authors are aware that the introduction of our Bti 
cost-model comes with a considerable degree of generali-
zation. While this feature makes the model easily appli-
cable for other settings, at the same time, it comes at cost 
of context-dependent prediction accuracy. Both goals 
are not achievable without accepting certain trade-offs. 
Thus, it is worth mentioning that our cost-model out-
comes only give a proxy for per capita programme costs 
and are expected to deliver more realistic results for set-
tings that resemble the study region it was developed in. 
Nonetheless, the authors are confident that this cost-
model not only sheds light into the cost structure of LSM 
programmes but that it will serve as a helpful implemen-
tation tool for larviciding programmes elsewhere by pro-
viding reliable cost estimates on technical, infrastructural 
and personnel needs.
Conclusions
Larvicide-based LSM is an additional, complementary 
tool for malaria control programmes that so far did not 
receive the attention it deserves for designing national 
and international policies. Particularly, in combination 
with LLINs and indoor residual spraying it proved to be 
a highly effective malaria vector control measure. For 
selected environments the use of remote sensing derived 
risk maps might be a promising approach to reduce the 
number of treated water bodies while, at the same time, 
keeping programme costs at reasonably low levels. 
Although today’s WHO recommendations promote the 
use of LSM mainly for urban areas with high population 
densities with the underlying idea of obtaining reduced 
costs per person, rural areas should not be considered a 
priori as ineligible for spraying interventions. Given the 
continuously adapting nature of malaria vector mos-
quitoes to insecticides, we make a case to shift more 
attention to hereof unaffected control strategies such as 
Bti based LSM. The latter might work as an important 
complementary tool to achieve the ambitious goals pur-
sued by the WHO’s global technical strategy for malaria 
between 2016 and 2030, to reduce malaria incidence and 
mortality by at least 90 % [1].
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